An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease

Allergan

Status: Completed

Conditions: Dry Eye Syndromes

Treatments: Drug: OPTIVE PLUS®

Study type: Observational

Funder types: Industry

Identifiers

NCT01711424

MAF/AGN/OPH/DE/012

Details and patient eligibility

About

This is an observational study of OPTIVE PLUS® in patients with dry eye disease in a routine clinical setting. Treatment decisions are made by the physician and reflect the physician's current standard of care.

Enrollment: 1,209 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of dry eye
• Physician decision to treat with OPTIVE PLUS® in accordance with the physician's standard practice

Exclusion criteria

• None

Trial design

1,209 participants in 1 patient group

OPTIVE PLUS®

Description:

Patients with dry eye prescribed OPTIVE PLUS® in accordance with physician standard practice.

Treatment:

Drug: OPTIVE PLUS®